Greenspring Advisors LLC Invests $452,000 in Danaher Corporation $DHR

Greenspring Advisors LLC purchased a new position in shares of Danaher Corporation (NYSE:DHRFree Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 2,373 shares of the conglomerate’s stock, valued at approximately $452,000.

Several other large investors have also recently added to or reduced their stakes in DHR. High Note Wealth LLC raised its stake in shares of Danaher by 19.2% during the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after buying an additional 47 shares in the last quarter. First Command Advisory Services Inc. boosted its stake in shares of Danaher by 4.4% in the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after buying an additional 47 shares in the last quarter. GW&K Investment Management LLC grew its holdings in Danaher by 8.4% during the fourth quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock worth $138,000 after acquiring an additional 47 shares during the period. Kestra Private Wealth Services LLC grew its holdings in Danaher by 0.3% during the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after acquiring an additional 48 shares during the period. Finally, SOL Capital Management CO raised its position in Danaher by 2.7% in the fourth quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock worth $430,000 after acquiring an additional 50 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Performance

Shares of NYSE DHR opened at $219.42 on Friday. The company has a 50-day simple moving average of $195.80 and a 200-day simple moving average of $192.61. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The company has a market cap of $154.25 billion, a PE ratio of 38.97, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.

Danaher (NYSE:DHRGet Free Report) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the previous year, the firm earned $0.77 earnings per share. Danaher’s revenue was up 5.5% compared to the same quarter last year. On average, equities analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently commented on DHR shares. HSBC reduced their price objective on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. TD Cowen reduced their price target on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Stifel Nicolaus decreased their price target on Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Finally, Piper Sandler assumed coverage on Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $228.91.

View Our Latest Research Report on DHR

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.